SCHEMBL6878003

SCHEMBL6878003

O=C1C=C(c2ccccc2)C(=O)N1CN1C(=O)C=C(c2ccccc2)C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RGS4 P49798 2/20 0.57
MAPT P10636 4/20 0.51
ALDH1A1 P00352 3/20 0.51
NPSR1 Q6W5P4 3/20 0.51
GAA P10253 2/20 0.51
CCR6 P51684 2/20 0.51
HPGD P15428 2/20 0.51
ALOX12 P18054 2/20 0.51
CACNA1B Q00975 2/20 0.51
APBA1 Q02410 2/20 0.51
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
BACE1 P56817 3/20 0.42
HCRTR1 O43613 1/20 0.41
S1PR4 O95977 1/20 0.41
HSP90AA1 P07900 1/20 0.41
S1PR1 P21453 1/20 0.41
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25288286 0.85 RGS4 (0.54) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL27595467 0.85 RGS4 (0.54) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL7857789 0.85 RGS4 (0.54) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL7774092 0.85 RGS4 (0.58) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL1535501 0.85 RGS4 (0.58) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL9171007 0.83 RGS4 (0.79) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL9562575 0.82 RGS4 (0.51) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL11069254 0.82 CA12 (0.53) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL7857853 0.82 RGS4 (0.51) RGS4MAPTALDH1A1NPSR1GAA
SCHEMBL5318341 0.80 RGS4 (0.50) RGS4MAPTALDH1A1NPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812311-B2 APPLYING PRECURSORS HAVING ETHYLNYL GROUP; CROSSLINKER AND A SOLVENT ONTO A SURFACE TO FORM ELECTRICALLY INSULATING LAYER; REACTING ETHYNYL GROUP WITH REACTIVE GROUP IN CARBON-CARBON BOND FORMING REACTION AND REACTING; CROSSLINKING HONEYWELL INTERNATIONAL INC. 2004-11-02 US disclosed
WO-2001019889-A9 HIGHLY STABLE PACKAGING SUBSTRATES AND BROMINATED INDANE DERIVATIVES ALLIED SIGNAL INC (US) 2002-10-03 WO disclosed
US-20020132053-A1 Highly stable packaging substrates HONEYWELL INTERNATIONAL, INC. 2002-09-19 US disclosed
EP-1226201-A1 HIGHLY STABLE PACKAGING SUBSTRATES AND BROMINATED INDANE DERIVATIVES AlliedSignal Inc. (US) 2002-07-31 EP disclosed
US-6346296-B1 ETHYNYL GROUPS ON BACKBONES, CROSSLINKING IN SOLVENTS ALLIEDSIGNAL INC. 2002-02-12 US disclosed
WO-2001019889-A1 HIGHLY STABLE PACKAGING SUBSTRATES AND BROMINATED INDANE DERIVATIVES ALLIEDSIGNAL INC. (US) 2001-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020132053-A1 Highly stable packaging substrates AGO2, EED, SYNJ2 RGS4 3968/4885MAPT 4241/4885ALDH1A1 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.